UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.503

Sortiert nach

Identification of Subgroups of Early Breast Cancer Patients at High Risk of Nonadherence to Adjuvant Hormone Therapy: Results of an Italian Survey

Clinical breast cancer, 2015-04, Vol.15 (2), p.e131-e137

2015

Link zum Volltext

Verfügbarkeit prüfen

Development of an e-health app to support women prescribed adjuvant endocrine therapy after treatment for breast cancer

Patient preference and adherence, 2018-01, Vol.12, p.2639-2647

2018

Link zum Volltext

Verfügbarkeit prüfen

Psychometric properties of the Beliefs about Medicine Questionnaire–adjuvant endocrine therapy (BMQ-AET) for women taking AETs following early-stage breast cancer

Health psychology open, 2017-07, Vol.4 (2), p.2055102917740469-2055102917740469

2017

Link zum Volltext

Verfügbarkeit prüfen

Patient-reported factors associated with adherence to adjuvant endocrine therapy after breast cancer: an integrative review

Breast cancer research and treatment, 2018-02, Vol.167 (3), p.615-633

2018

Link zum Volltext

Verfügbarkeit prüfen

Estrogen deprivation effects of endocrine therapy in breast cancer patients: Incidence, management and outcome

Cancer treatment reviews, 2023-11, Vol.120, p.102624-102624, Article 102624

2023

Link zum Volltext

Verfügbarkeit prüfen

Tailoring adjuvant endocrine therapy in early breast cancer: When, how, and how long?

Cancer treatment reviews, 2022-11, Vol.110, p.102445-102445, Article 102445

2022

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant endocrine therapy non-initiation and non-persistence in young women with early-stage breast cancer

Breast cancer research and treatment, 2023-02, Vol.197 (3), p.547-558

2023

Link zum Volltext

Verfügbarkeit prüfen

Clinical factors associated with patterns of endocrine therapy adherence in premenopausal breast cancer patients

Breast cancer research : BCR, 2024-04, Vol.26 (1), p.59-59

2024

Link zum Volltext

Verfügbarkeit prüfen

Identification of patient subgroups who benefit from a behavioral intervention to improve adjuvant endocrine therapy adherence: a randomized-controlled trial

Breast cancer research and treatment, 2024-04, Vol.204 (3), p.547-559

2024

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and toxicity of extended aromatase inhibitors after adjuvant aromatase inhibitors-containing therapy for hormone-receptor-positive breast cancer: a literature-based meta-analysis of randomized trials

Breast cancer research and treatment, 2020, Vol.179 (2), p.275-285

2020

Link zum Volltext

Verfügbarkeit prüfen

Factors influencing adherence to adjuvant endocrine therapy in breast cancer-treated women: using real-world data to inform a switch from acute to chronic disease management

Breast cancer research and treatment, 2020-08, Vol.183 (1), p.189-199

2020

Link zum Volltext

Verfügbarkeit prüfen

Bridging the age gap in breast cancer. Impacts of omission of breast cancer surgery in older women with oestrogen receptor positive early breast cancer. A risk stratified analysis of survival outcomes and quality of life

European journal of cancer (1990), 2021-01, Vol.142, p.48-62

2021

Link zum Volltext

Verfügbarkeit prüfen

Influence of adherence to adjuvant endocrine therapy on disease-free and overall survival: a population-based study in Catalonia, Spain

Breast cancer research and treatment, 2019-06, Vol.175 (3), p.733-740

2019

Link zum Volltext

Verfügbarkeit prüfen

Comparative efficacy and safety of extended adjuvant endocrine therapy for hormone receptor-positive early breast cancer: a Bayesian network meta-analysis

Breast cancer research and treatment, 2024, Vol.203 (1), p.13-28

2024

Link zum Volltext

Verfügbarkeit prüfen

Religion and spirituality: their role in the psychosocial adjustment to breast cancer and subsequent symptom management of adjuvant endocrine therapy

Supportive care in cancer, 2021-06, Vol.29 (6), p.3017-3024

2021

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant endocrine therapy for premenopausal women: risk stratification, type and duration1

Breast (Edinburgh), 2019-11, Vol.48, p.S85-S88

Francis, Prudence A.

2019

Link zum Volltext

Verfügbarkeit prüfen

Understanding adjuvant endocrine therapy persistence in breast Cancer survivors

BMC cancer, 2018-07, Vol.18 (1), p.732-732, Article 732

2018

Link zum Volltext

Verfügbarkeit prüfen

Persistence to extended adjuvant endocrine therapy following Breast Cancer Index (BCI) testing in women with early-stage hormone receptor-positive (HR +) breast cancer

BMC cancer, 2023-06, Vol.23 (1), p.606-606, Article 606

2023

Link zum Volltext

Verfügbarkeit prüfen

Predicting adjuvant endocrine therapy initiation and adherence among older women with early-stage breast cancer

Breast cancer research and treatment, 2020-12, Vol.184 (3), p.805-816

2020

Link zum Volltext

Verfügbarkeit prüfen

Factors associated with worsening sexual function during adjuvant endocrine therapy in a prospective clinic-based cohort of women with early-stage breast cancer

Breast cancer research and treatment, 2022-12, Vol.196 (3), p.535-547

2022

Link zum Volltext

Verfügbarkeit prüfen

Interventions to promote adherence to endocrine therapy among breast cancer survivors: A meta‐analysis

Psycho-oncology (Chichester, England), 2019-02, Vol.28 (2), p.255-263

2019

Link zum Volltext

Verfügbarkeit prüfen

The Association Between Out-of-Pocket Costs and Adherence to Adjuvant Endocrine Therapy Among Newly Diagnosed Breast Cancer Patients

American journal of clinical oncology, 2018-07, Vol.41 (7), p.708-715

2018

Link zum Volltext

Verfügbarkeit prüfen

Factors associated with intentional and unintentional non‐adherence to adjuvant endocrine therapy following breast cancer

European journal of cancer care, 2018-01, Vol.27 (1), p.e12601-n/a

2018

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Initial 5 Years of Adjuvant Endocrine Therapy in Postmenopausal Hormone Receptor-Positive Breast Cancer: A Systematic Review and Network Meta-Analysis

Frontiers in pharmacology, 2022-05, Vol.13, p.886954-886954

2022

Link zum Volltext

Verfügbarkeit prüfen

Adherence to oral hormonal anticancer agents in breast cancer

Tumori, 2023-06, Vol.109 (3), p.262-268

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.503

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.425)
Mit Volltextzugriff
(1.347)

Publikationsform

Sprache

Englisch
(1.475)
Japanisch
(140)
Deutsch
(15)
Französisch
(10)
Russisch
(3)
Spanisch
(2)
Chinesisch
(1)

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.319)
Life Sciences & Biomedicine
(1.290)
Humans
(1.166)
Female
(1.067)
Breast Cancer
(1.021)
Endocrine Therapy
(940)
Oncology
(932)
Breast Neoplasms - Drug Therapy
(731)
Chemotherapy, Adjuvant
(641)
Middle Aged
(569)
Aged
(473)
Chemotherapy
(468)
Cancer
(416)
Antineoplastic Agents, Hormonal - Therapeutic Use
(405)
Cancer Therapies
(396)
Adult
(393)
Tumors
(359)
Breast Neoplasms - Pathology
(350)
Adjuvant Treatment
(343)
Medicine
(342)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Breast Cancer Research And Treatment
(195)
Breast
(63)
Bmc Cancer
(37)
Cancer
(34)
Clinical Breast Cancer
(31)
European Journal Of Cancer
(27)
Annals Of Surgical Oncology
(26)
Annals Of Oncology
(25)
Supportive Care In Cancer
(25)
Plos One
(23)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

Identification of Subgroups of Early Breast Cancer Patients at High Risk of Nonadherence to Adjuvant Hormone Therapy: Results of an Italian Survey

Development of an e-health app to support women prescribed adjuvant endocrine therapy after treatment for breast cancer

Psychometric properties of the Beliefs about Medicine Questionnaire–adjuvant endocrine therapy (BMQ-AET) for women taking AETs following early-stage breast cancer

Patient-reported factors associated with adherence to adjuvant endocrine therapy after breast cancer: an integrative review

Estrogen deprivation effects of endocrine therapy in breast cancer patients: Incidence, management and outcome

Tailoring adjuvant endocrine therapy in early breast cancer: When, how, and how long?

Adjuvant endocrine therapy non-initiation and non-persistence in young women with early-stage breast cancer

Clinical factors associated with patterns of endocrine therapy adherence in premenopausal breast cancer patients

Identification of patient subgroups who benefit from a behavioral intervention to improve adjuvant endocrine therapy adherence: a randomized-controlled trial

Efficacy and toxicity of extended aromatase inhibitors after adjuvant aromatase inhibitors-containing therapy for hormone-receptor-positive breast cancer: a literature-based meta-analysis of randomized trials

Factors influencing adherence to adjuvant endocrine therapy in breast cancer-treated women: using real-world data to inform a switch from acute to chronic disease management

Bridging the age gap in breast cancer. Impacts of omission of breast cancer surgery in older women with oestrogen receptor positive early breast cancer. A risk stratified analysis of survival outcomes and quality of life

Influence of adherence to adjuvant endocrine therapy on disease-free and overall survival: a population-based study in Catalonia, Spain

Comparative efficacy and safety of extended adjuvant endocrine therapy for hormone receptor-positive early breast cancer: a Bayesian network meta-analysis

Religion and spirituality: their role in the psychosocial adjustment to breast cancer and subsequent symptom management of adjuvant endocrine therapy

Adjuvant endocrine therapy for premenopausal women: risk stratification, type and duration1

Understanding adjuvant endocrine therapy persistence in breast Cancer survivors

Persistence to extended adjuvant endocrine therapy following Breast Cancer Index (BCI) testing in women with early-stage hormone receptor-positive (HR +) breast cancer

Predicting adjuvant endocrine therapy initiation and adherence among older women with early-stage breast cancer

Factors associated with worsening sexual function during adjuvant endocrine therapy in a prospective clinic-based cohort of women with early-stage breast cancer

Interventions to promote adherence to endocrine therapy among breast cancer survivors: A meta‐analysis

The Association Between Out-of-Pocket Costs and Adherence to Adjuvant Endocrine Therapy Among Newly Diagnosed Breast Cancer Patients

Factors associated with intentional and unintentional non‐adherence to adjuvant endocrine therapy following breast cancer

Efficacy and Safety of Initial 5 Years of Adjuvant Endocrine Therapy in Postmenopausal Hormone Receptor-Positive Breast Cancer: A Systematic Review and Network Meta-Analysis

Adherence to oral hormonal anticancer agents in breast cancer

Suchergebnisse filtern